Thyroid Hormone Regulation And Glp-1

GLP-1RA: Glucagon-like peptide-1receptor agonists; PK: pharmacokinetics; TPO:thyroidperoxidase antibody; TgAb: thyroglobulin antibody; TSH receptor Ab:thyroidstimulatinghormone(TSH) receptor antibody These pathways are hypothesis-generating only, as current evidence is limited.GLP-1RAs may potentially influence AITD indirectly through weight loss, improved insulin sensitivity, anti ...

Dec 19, 2024 ·Obesity and family practice experts share when it’s safe to prescribeGLP-1receptor agonists to patients withthyroidproblems and what conditions should preclude the medications.View allTo clarify theregulatoryeffect ofTHon glucose homeostasis, we employed an animal treatment protocol as previously reported. To achieve maximal responses toTHtreatment, mice were renderedhypothyroidfirst by methimazole (MMI) treatment and then received daily injection of T3, the active form ofTHwith a short half-life in serum, for five day...See full list on nature.comWe also found thatGLP-1treatment could elevate insulin levels, decrease glucose levels,andimprove oral glucose tolerance in MMI mice (Fig. 1h–jandSupplementary Fig. 1p). To test whether the incretinhormone GLP-1was the predominant contributor to the observed improvement of glucose homeostasis, we employed exendin 9–39 (Ex-9), aGLP-1recept...See full list on nature.comAs the glucose-lowering effect has been reported for either TRβ-selective agonist or liver-specific TRβ-selective agonist in obese mice17,18, we then employed mice lacking TRβ in the liver (LTRβKO mice) we developed recently (Supplementary Fig. 2d, e) to test whether the hepatic TH signaling was responsible for the elevation ofGLP-1 andinsulin le...See full list on nature.comConsistently, we found that pharmacological activation of hepatic TRβ by daily injection of MB07811, a liver-targeted TRβ-selective agonist, for five days could increase the plasma levels ofGLP-1 andinsulin, decrease the blood glucose levels,andas well as improve the oral glucose tolerance in MMI mice (Fig. 3a–d), which mimicked the metabolic e...See full list on nature.comTo understand the molecular mechanism underlying the glucose-lowering effect of hepatic TH signaling, we performed RNA-seq followed by KEGG pathway analysis to identify hepatic genes or pathways regulated by T3 (Fig. 4a). We found that 3251 genes were differentially expressed in the liver of MMI + T3-5d mice compared to MMI mice (GSE184261) (Fig. 4...See full list on nature.comRecent evidence suggests that a couple of non-12α-OH BAs, including T(α/β)MCA, (T/G)UDCA,and(T)HDCA, can exert FXR-antagonistic effects4,9,10,29, while intestinal FXR inhibition is able to stimulateGLP-1productionandsecretion in L cell11. We then tested whether the levels of FXR-antagonistic BAs were altered after T3 treatment. In agreement w...See full list on nature.comTo dissect the contribution of the augmentation of non-12α-OH FXR-antagonistic BAs to the improved glucose metabolism after T3 daily injection, MMI mice were fed a diet supplemented with TβMCA, the most abundant murine FXR-antagonistic BA, for five days. We found that TβMCA administration increased the mRNA levels of Gcg in the ileum of MMI mice (F...See full list on nature.comTo test whether intestinal FXR signaling was essential for the T3 action observed in this study, intestine-specific FXR-null mice (IFXRKO) were employed31. We found that the T3 effects on the mRNA expression of ileal Gcg,GLP-1, insulin,andglucose levels,andoral glucose tolerance were all abolished in the MMI-treated IFXRKO mice (Fig. 7a–cand...See full list on nature.comTo assess the physiological relevance of our above findings in this study, we analyzed the relationship between the levels ofGLP-1 andT3 in human study participants with normalthyroidfunction. In a cohort of 30 euthyroid human study participants, a negative correlation between free T3 levelsandtotal cholesterol levels was observed (Supplement...See full list on nature.comJan1, 2026 ·Glucagon-like Peptide-1receptor agonists (GLP-1RAs) are antidiabetic medications, with conflicting reports about their relationship withthyroiddiseases. This study investigates their effects onthyroidfunction and nodules in patients with diabetes.Jun 13, 2024 ·The increasing utilization of Glucagon-like Peptide-1receptor agonists (GLP-1RAs) in managing type 2 diabetes mellitus has raised interest regarding their impact onthyroidfunction. In fact, while these agents are well known for their efficacy in glycemic control and weight management, their association withthyroiddisorders requires clarification due to the complex interplay between ...May 15, 2025 ·Navigating Health and Wellness: Insights onGLP-1Medications,ThyroidHealth, andHormoneTherapy In a recent podcast episode, McCall McPherson delves into a variety of health topics, focusing onGLP-1medications,thyroidhealth, andhormonetherapy. The episode is interactive, with McCall addressing questions submitted by listeners via Instagram, offering a wealth of insights and personal ...Oct 28, 2025 ·Thyroidhealth significantly influences metabolism, insulin sensitivity, and weightregulation. Whenthyroidhormonesare low, symptoms like fatigue, weight gain, and insulin resistance can interfere with the effectiveness ofGLP-1medications.

Moving forward, it's essential to keep these visual contexts in mind when discussing Thyroid Hormone Regulation And Glp-1.

Jan1, 2026 ·Glucagon-like Peptide-1receptor agonists (GLP-1RAs) are antidiabetic medications, with conflicting reports about their relationship withthyroiddiseases. This study investigates their effects onthyroidfunction and nodules in patients with diabetes.

As we can see from the illustration, Thyroid Hormone Regulation And Glp-1 has many fascinating aspects to explore.